title: Effect of thyroxine replacement on creatinine, insulin-like growth factor 1, acid-labile subunit, and vascular endothelial growth factor.
authors.affiliation: Department of Internal Medicine, Division of Endocrinology and Diabetes, University Hospital of Zurich, CH-8091 Zurich, Switzerland.
authors.forename: Christoph
authors.initials: C
authors.lastname: Schmid
authors.forename: Michael
authors.initials: M
authors.lastname: Brändle
authors.forename: Cornelia
authors.initials: C
authors.lastname: Zwimpfer
authors.forename: Jürgen
authors.initials: J
authors.lastname: Zapf
authors.forename: Peter
authors.initials: P
authors.lastname: Wiesli
mesh_terms: D000328:Adult; D002352:Carrier Proteins / Q000097:blood*; D003404:Creatinine / Q000097:blood*; D005260:Female; D006023:Glycoproteins / Q000097:blood*; D020249:Hormone Replacement Therapy; D006801:Humans; D007037:Hypothyroidism / Q000097:blood / Q000188:drug therapy; D036341:Intercellular Signaling Peptides and Proteins / Q000097:blood*; D008297:Male; D013974:Thyroxine / Q000627:therapeutic use*; D042461:Vascular Endothelial Growth Factor A / Q000097:blood*
chemical_list: D002352:Carrier Proteins; D006023:Glycoproteins; D036341:Intercellular Signaling Peptides and Proteins; D042461:Vascular Endothelial Growth Factor A; C075944:insulin-like growth factor binding protein, acid labile subunit; C065700:myotrophin; D003404:Creatinine; D013974:Thyroxine